Today is rare disease day! To me it is the representation of caring, hope and strength. Together we are stronger !💪💪 - extremely grateful for all the support, guidance, understanding and care from some many people. ❤️❤️ Mark Hofmeyer Paula Ferrada MD FACS FCCM MAMSE Peter Grayson Kaitlin Quinn

Congratulations, Dr. Sarthak Gupta Sarthak Gupta, MD, on becoming an Associate Research Physician in NIH Intramural NIAMS NIH Intramural NIAMS 🎉🍾!

We on the NIH Staff Clinician Council NIH Staff Clinician Council are proud of your success and look forward to what comes next for you.

This one is also top 10 for me. I might have to keep a running thread of my favorite moments from the Glaucomflecken Cinematic Universe

News: Pioglitazone may have CVD risk-reducing potential for patients with #lupus , suggests research by Sarfaraz Hasni (@NIH) Sarthak Gupta, MD Massimo -Max- Gadina Nehal N. Mehta & team Annals of the Rheumatic Diseases bit.ly/3ducJut

Latest NIH study shows pioglitazone (Actos, diabetes drug) helps #lupus patients. Good job to Sarfaraz Hasni Sarthak Gupta, MD Dr. Kaplan and the entire team!: ard.bmj.com/content/early/…

#NIDCR NIH is testing a new treatment using tofacitinib in people with #Sjögren 's syndrome. Participants are compensated. Contact NIH Clinical Center Office of Patient Recruitment at 866-444-8810. Refer to study #20-D-0131 go.usa.gov/xF63H #sjogrens

New Pub! Gain-of-function mutations in ALPK1 cause an NF- κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. Published today in: Annals of the Rheumatic Diseases

🤯

Adult volunteers diagnosed with #Sjögrens syndrome needed in a #clinicaltrial by #NIDCR NIH to test the drug tofacitinib in treating Sjögrens. Compensation provided. Contact: Office of Patient Recruitment 866-444-8810 study no.20-D-0131 go.usa.gov/xF63H

Clinical trials require a partnership between patients and providers before, during, and after the study. Only together can we treat and prevent Sjogrens Disease Sarthak Gupta, MD Sarfaraz Hasni #sjogrens #sjögrens #drymouth #dryeyes #autoimmunedisease #thanksNIDCR

New treatment shows promise in reducing the risk of cardiovascular disease in people with #lupus . Learn more: go.usa.gov/xeQ8f
#RheumTwitter

We have now published a series of papers detailing the involvement of LAMP3 in the pathophysiology of #sjögrenssyndrome .

This #tweetorial overview of our latest work from Tanaka, Warner, and Chiorini, et al. from the NIDCR @NIH AAV Biology Section and the Salivary Disorders Unit.

Macrophage Activation Syndrome (MAS/HLH) is not the only STORM ⛈ to fear in #sJIA and #AOSD . In this case, a genetic factor (HLA-DRB1*15) may help to identify those who are at high risk of DRESS, a different type of cytokine storm! See details below:

ard.bmj.com/content/early/…

Congrats to the authors for this study out in the ⁦NEJM⁩. ⁦adelmandl⁩ ⁦Peter Burbelo⁩ & Lee Weinstein ⁦NIDDK⁩ ⁦NIDCR @NIH⁩ Parathyroid Hormone Resistance and Autoantibodies to the PTH1 Receptor | NEJM nejm.org/doi/full/10.10…

Sarcopenia in Rheumatic diseases: what does the imaging show?

Read all about the Radiological findings of this entity in our latest review.

Wonderful collaboration with Stanford Radiology Stanford MSK Radiology Wake Forest Baptist Diagnostic Radiology NIAMS NIH Clinical Center

Just a couple hours east we have a RCT to test tofacitinib in SjD NIDCR @NIH NIAMS Sarthak Gupta, MD

So.Many.Times.. 🤦🏽‍♂️

Congratulations to Mariana Kaplan, M.D., on her election to National Academy of Medicine for seminal contributions that significantly advanced understanding of the pathogenic role of the innate immune system in systemic #AutoimmuneDiseases , atherosclerosis, & immune-mediated vasculopathies.

Typical Rheum consult.... 😆😆